LH vs FSH: Understanding the Two Gonadotropins
LH and FSH are both pituitary gonadotropins suppressed by AAS use, but they control different testicular functions and recover at different rates, making their distinction critical for PCT monitoring and fertility assessment.
Overview
Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are glycoprotein hormones secreted by the anterior pituitary in response to GnRH pulses. Both are suppressed to near-zero during AAS use. LH stimulates Leydig cells to produce testosterone, while FSH stimulates Sertoli cells to support spermatogenesis. During PCT recovery, LH typically recovers faster than FSH, and testosterone production can resume before sperm production normalizes. Understanding which gonadotropin is lagging helps determine whether the recovery problem is testosterone production (LH-dependent), sperm production (FSH-dependent), or both.
Side-by-Side Comparison
| Attribute | LH | FSH |
|---|---|---|
| Primary target | Leydig cells (testes) | Sertoli cells (testes) |
| Primary function | Stimulates testosterone production | Stimulates spermatogenesis |
| Normal male range | 1.7-8.6 IU/L | 1.5-12.4 IU/L |
| Half-life | ~20 minutes | ~3-4 hours |
| Suppression on AAS | Near-zero within 2-4 weeks | Near-zero within 2-4 weeks |
| Recovery speed post-cycle | Faster (weeks to months) | Slower (months to years for full spermatogenesis) |
| Additional regulators | Testosterone, estradiol (negative feedback) | Inhibin B from Sertoli cells (additional negative feedback) |
| PCT relevance | Primary recovery marker for testosterone production | Primary recovery marker for fertility |
| Clinical test for function | Serum testosterone response | Semen analysis (sperm count, motility) |
Key Differences
LH acts on Leydig cells and drives testosterone production. Its recovery is the primary indicator of hormonal axis restart during PCT. FSH acts on Sertoli cells and drives spermatogenesis. Its recovery is the primary indicator of fertility restoration but is not captured by standard hormone panels alone; semen analysis is needed to confirm functional sperm production.
LH recovery typically precedes FSH recovery by 2-4 weeks. LH has a shorter half-life (approximately 20 minutes) than FSH (approximately 3-4 hours), making LH more sensitive to acute changes in GnRH pulsatility.
FSH is additionally regulated by inhibin B, a Sertoli cell product, providing a second feedback loop independent of testosterone. This means FSH can remain suppressed even after LH and testosterone have normalized if Sertoli cell function has not yet recovered.
When to Use Which
Monitor LH as your primary indicator of HPTA restart during PCT. If LH is rising, the pituitary is responding to SERMs and the axis is reactivating.
Monitor FSH if fertility is a concern. A normal FSH does not guarantee normal sperm production (semen analysis is needed), but a persistently suppressed FSH indicates spermatogenesis has not restarted.
In the "failed PCT" scenario, the LH/FSH pattern discriminates between pituitary failure (both low) and testicular failure (both elevated with low testosterone). An isolated FSH elevation with normal LH can indicate selective Sertoli cell damage.
Clinical Context
In clinical endocrinology, the LH/FSH ratio and their absolute values help classify hypogonadism. Low LH and FSH with low testosterone indicates hypogonadotropic (secondary) hypogonadism, pointing to a pituitary or hypothalamic problem. Elevated LH and FSH with low testosterone indicates hypergonadotropic (primary) hypogonadism, pointing to testicular failure. In the context of AAS recovery, the most common pattern is secondary hypogonadism (suppressed pituitary), which is potentially reversible with SERMs. Primary hypogonadism post-AAS suggests Leydig cell damage and carries a worse prognosis.
Bodybuilder Context
For enhanced athletes, the practical distinction matters most during PCT monitoring. LH is the 'did my axis restart?' marker. FSH is the 'can I still have children?' marker. Most PCT protocols focus on LH-driven testosterone recovery because that is what resolves symptoms (low energy, low libido, mood changes). Fertility recovery receives less attention but is increasingly relevant as AAS users plan families. The research shows spermatogenesis recovery lags hormonal recovery significantly: 90% of men recover adequate sperm counts within 12 months, but this can take up to 24 months after heavy AAS use.
Frequently Asked Questions
Related Pages
Compare your own results
Upload your blood tests to track both markers side by side with personalised trends and AI-powered analysis.